SeekInCare Blood Test Can Detect More Than 20 Cancer Types
SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.
SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.
Higher levels of certain sex hormones are associated with an increased risk of some gastrointestinal cancers, a meta-analysis suggests.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
ZB131 is a proprietary monoclonal antibody designed to target cancer-specific plectin with high affinity and specificity.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
The gene sequencing panel PancreaSeq can accurately classify pancreatic cysts as benign or potentially cancerous, according to researchers.
SY-5609 is a highly selective and potent oral inhibitor of the cyclin-dependent kinase 7.
Researchers found that 30% of pancreatic adenocarcinoma trials completed from 2010 through 2020 did not have results available.
Perioperative adaptive dynamic therapy can improve overall survival in patients with localized pancreatic cancer, new research suggests.
In addition to improved overall survival, patients in the neoadjuvant arm had longer disease-free survival and locoregional failure-free intervals.